English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Dear Colleagues, Our journal, Brazilian Annals of Dermatology, was indexed in PubMed in 2009, and in 2010 had its Impact Factor (IF) assessed and disclosed in the Journal Citation Report (JCR). As you know, in spite of its limitations, the IF of a certain journal is its “business card”, and its proof of quality and reputation, and also the parameter for Capes in determining the Qualis index of journals in general. The IF is calculated by dividing the number of citations the journal receives in a certain year for the articles published (for example: in 2017), by the number of articles published in the two previous years (in the example: 2016 and 2015). In 2017, it corresponded to 357 citations to 404 published articles. Therefore, the IF of 2017 was of 0.884. What qualifies us by Capes as a B3 journal (from A1 to B5). And, of 63 dermatology journals that were assessed/measured by the JCR, we are in the 60th place. We cannot accept such classification. It does not do justice to Brazilian dermatology. We have been taking multiple initiatives to reverse this picture, such as: reducing the overall number of articles, particularly case reports, pursuing review articles and more attractive and upto-date CME, favoring publications in the scope of tropical dermatology, and being very strict regarding the articles submitted. However, we understand this alone is not enough. We need to increase our visibility, particularly towards our international peers; with this goal we need to speed up our publications with the long-awaited 132

Changes in the Brazilian Annals of Dermatology. Unpostponable initiatives